Guardant Health
GH
#1176
Rank
C$28.16 B
Marketcap
C$212.44
Share price
-1.01%
Change (1 day)
242.15%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

ESG Reports

Thumbnail Guardant Health
 ESG Report 2024

ESG Report 2024

Language: English

View ESG Report
Thumbnail Guardant Health
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report